Faron Pharmaceuticals CMO “looking forward to a year filled with good data for the patients”

–News Direct–

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief medical officer Marie-Louise Fjällskog updates Proactive's Thomas Warner the clinical-stage biopharmaceutical company's wholly-owned precision immunotherapy asset, Bexmarilimab.

Fjällskog says that she's “looking forward to a year filled with good data for the patients.”

Contact Details

Proactive UK Ltd

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/faron-pharmaceuticals-cmo-looking-forward-to-a-year-filled-with-good-data-for-the-patients-393299269